Style | Citing Format |
---|---|
MLA | Khorsandi Z, et al.. "Sustainable Synthesis of Potential Antitumor New Derivatives of Abemaciclib and Fedratinib Via C-N Cross Coupling Reactions Using Pd/Cu-Free Co-Catalyst." Molecular Catalysis, vol. 517, no. , 2022, pp. -. |
APA | Khorsandi Z, Keshavarzipour F, Varma RS, Hajipour AR, Sadeghialiabadi H (2022). Sustainable Synthesis of Potential Antitumor New Derivatives of Abemaciclib and Fedratinib Via C-N Cross Coupling Reactions Using Pd/Cu-Free Co-Catalyst. Molecular Catalysis, 517(), -. |
Chicago | Khorsandi Z, Keshavarzipour F, Varma RS, Hajipour AR, Sadeghialiabadi H. "Sustainable Synthesis of Potential Antitumor New Derivatives of Abemaciclib and Fedratinib Via C-N Cross Coupling Reactions Using Pd/Cu-Free Co-Catalyst." Molecular Catalysis 517, no. (2022): -. |
Harvard | Khorsandi Z et al. (2022) 'Sustainable Synthesis of Potential Antitumor New Derivatives of Abemaciclib and Fedratinib Via C-N Cross Coupling Reactions Using Pd/Cu-Free Co-Catalyst', Molecular Catalysis, 517(), pp. -. |
Vancouver | Khorsandi Z, Keshavarzipour F, Varma RS, Hajipour AR, Sadeghialiabadi H. Sustainable Synthesis of Potential Antitumor New Derivatives of Abemaciclib and Fedratinib Via C-N Cross Coupling Reactions Using Pd/Cu-Free Co-Catalyst. Molecular Catalysis. 2022;517():-. |
BibTex | @article{ author = {Khorsandi Z and Keshavarzipour F and Varma RS and Hajipour AR and Sadeghialiabadi H}, title = {Sustainable Synthesis of Potential Antitumor New Derivatives of Abemaciclib and Fedratinib Via C-N Cross Coupling Reactions Using Pd/Cu-Free Co-Catalyst}, journal = {Molecular Catalysis}, volume = {517}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Khorsandi Z AU - Keshavarzipour F AU - Varma RS AU - Hajipour AR AU - Sadeghialiabadi H TI - Sustainable Synthesis of Potential Antitumor New Derivatives of Abemaciclib and Fedratinib Via C-N Cross Coupling Reactions Using Pd/Cu-Free Co-Catalyst JO - Molecular Catalysis VL - 517 IS - SP - EP - PY - 2022 ER - |